123
Dr Patrick Dixon Chairman Global Change Ltd Fellow, Centre for Management Development, London Business School Future of Health key health trends and what they mean for pharma manufacturing

Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Embed Size (px)

Citation preview

Page 1: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Dr Patrick Dixon Chairman Global Change LtdFellow, Centre for Management Development, London Business School

Future of Health key health trends and what they mean for

pharma manufacturing

Page 2: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 3: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Ins$tu$onalBlindness-beyonddata

Page 4: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Expectcompe**onbetweenpharma,biotech,medtechandinfotechinfinding

answerstomajorcondi*onsandinhealthspending

Page 6: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 7: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 8: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 9: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 10: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 11: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 12: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• ClicktoeditMastertextstyles

12

Page 13: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 14: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• ClicktoeditMastertextstyles

14

Page 15: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 16: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Worldcanchangefasterthanyoucanholdaboardmee*ng

orbuildanewfactory

Page 17: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Agility

Page 18: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

ONEWORDwilldrivethe

futureofhealth

Page 19: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

The future is aboutEMOTION

Page 20: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 21: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

REPUTATIONRISK

Page 22: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 23: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 24: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

24

Page 25: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Demographicswillbegreatestpredictorof

futuredemand

Page 26: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 27: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

85% of world population will be living in emerging

markets in 10 years

Future of TEVA is in emerging markets

Page 28: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

300 million move to cities in China and 475 million to cities in Africa by 2030

Page 29: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Science,technologyengineering,maths

Page 30: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

MostSTEMgraduatesinemergingmarkets

Page 31: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

ChinaandIndiadominate

STEMdegreesincludingpost-graduate/PhDs

Page 32: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Europe Dying 4 couples to produce single great-grand child

1 million in Italy over 90 years old by 2026

Page 33: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Title Text• Body Level One

– Body Level Two

• Body Level Three

– Body Level Four

» Body Level Five

Page 34: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 35: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

!35

Page 36: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

>65%spend>65yearsold>1billion>60by2020

Page 37: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

ChronicCondi*ons–Mul*pleNeeds

•100millionAmericanshavechroniccondi$ons•80%ofhealthspending•88%ofallprescrip$ons•70%ofphysicianvisits•66%Medicarecost=peoplewith5+condi$ons

AlmostallcausedbypeoplegeTngolder

Page 38: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 39: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

PharmaCompanies

WILLfindnewblockbusterse.g.Alzheimers/Obesity

Page 40: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

1in3babiesinNewYorkwilldevelopadult-typediabetes-cost$100bnayear

Page 41: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Manyhealthcostswill

FALL

Page 42: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

PatentExpiryondrugsalesworth$225bn2011-2016

Page 43: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Over700biosimilarsindevelopment

Page 44: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 45: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

EachbiosimilarneedstoscoreBETTERTHANOTHERSononeormoreoftrust,price,easeofuse,pa*ent

experience,clinicaloutcome,adverseevents,physiciansupport

Page 46: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Compe*ngoncostaloneisa

dangerousstrategy

Page 47: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

FutureofHospitals

Page 48: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Smartimagingwilltransformdiagnosisandtreatment

Page 49: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 50: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 51: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 52: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

3DModelling

•thankstoL.Soler

Page 53: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 54: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 55: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 56: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Micro-surgerywillalsotransform

hospitalcare

Page 57: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• $75bn endoscopy market by 2022

Page 58: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• 125,000 stents or carotid surgery a year in US

Page 59: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 60: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

MorespecialistcentresLengthofhospitalstayrequiredperprocedure

oreventwillfall10-20%by2025

Page 61: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 62: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

RapiddischargeandsupportPreven*onofadmissions

Page 63: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

HomeCarewillneedtogrowveryfastespeciallyfor

oldpeople

Page 64: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Growthcommunitynursing

Page 65: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Enhancedcareassistantss

Page 66: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

WearableHealthDeviceswillbealmost

universal

Page 67: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 68: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• Diabetes, congestive heart failure, obstructive pulmonary

• 2.2 million at home

• > $22bn by 2015

•Mobile telephony

Page 69: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

16yearsofcontracep*vesonsinglechip

Page 70: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Cough,respira*on,wheeze,heartrate

Automated Device for Asthma Management, or ADAM, by Health Care Originals

Page 71: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Home Tele-Monitoring

Page 72: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 73: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Mostpa*entswillknowmorethantheir

physiciansabouttheircondi*on-impactonprescribing-risks

Page 74: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Instantclinic-atfixedcost

Page 75: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 76: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Biotechwilldrivemostpharma

innova*on

Page 77: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 78: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 79: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Mouse Retina

Page 80: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Build Nanotech Robots as Biotech Therapies

Page 81: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Confidential

HSV1causescoldsores.WhenengineeredasSeprehvir(HSV-1716),itisharmlesstohealthy@ssue.

•Oncolytic viruses • Infect and kill cancer tumour cells •No damage to healthy tissue •Evidence of impact in clinical trials •Able to deliver new genes into cancer cells •Micro-dose chemo, micro-dose radiotherapy

Viruses to cure cancer

Page 82: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

ElectronicMedicalRecordswillmean

beaerdecisionsusingBigData+risks

Page 83: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 84: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Product scanning means safety

Computer-aided decisions save lives and time

Page 85: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Ottawa Hospital, Ontario - 3000 ipads Mayo Clinic - 2000 ipads

Page 86: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

400,000deathsayearinAmericafromavoidablemedicalerrors

Whyarewecollec*ngdata-forpa*entuseortokeepsomeoneoutofhospital?

Page 87: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

• Zettabyte = 1024 Exabytes Exabyte = 1024 Petabytes Petabyte = 1024 Terabytes Terabytes = 1024 Gigabytes That's a data explosion of 44x in approximately 10 years.

Big Data

Page 88: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Genescreeningwilldominatediseasepreven*onand

treatment

Page 89: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Less than £1000 per person

Page 90: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

OrganRepairwillberou*neusingowncells

Page 91: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

•Pigsteethgrowninsiderats•Micegrownewteethfromnervecells/gum$ssue

Grow New Teeth

Page 92: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 93: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Repair Heart / Brain / Retina / Spine

Page 94: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Rod photoreceptors (in green) within a "mini retina" derived from human induced Pluripotent Stem Cells in the lab. Courtesy of Johns Hopkins Medicine

Page 95: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Re*nacellsfromadultskincells

Page 96: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 97: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Newinsulincellsincapsulestoprotectfrom

immunesystem

Repair Pancreas in diabetics

Page 98: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

98

Competition from implanted devices containing insulin

Page 99: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

An*-Ageingwillbeaglobal

obsession-withrapidprogress

Page 100: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Performance

Shift in retail health care from health treatment to life enhancement

Page 101: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Want to look better - $200bn pa by 2020

Page 102: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

may be

Want to think better......

•20%studentsinUS/UKusememorydrugstopassexams

Page 103: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

7mechanismsofageinginanimalandhumancells

•Celllossoratrophywithoutreplacement•Nuclearmuta$onsandepimuta$onsthatcausecancer•Mitochondrialmuta$ons•Cellsenescence(deathresistance)•Junkinsidecells•Junkoutsidecells•Cross-linksbetweencells(egelas$n)

Page 104: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Worn out Mitochondria – Energy Boost

R-alpha-lipoic acidAcetyl-L-carnitine

Page 105: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Treatment which restores and maintains the youthful elasticity of

hardened arteries – and helps wrinkled skin. Global sales?

Low blood pressure and total body lift

Alteon

Page 106: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Slow or no ageing is a reality

• Rockfish, Turtles, some Whales

• No signs of getting old

Rougheye rockfish (Sebastes aleutianus) — 205 years Aldabra Giant Tortoise — 255 years Lobsters are believed to live 100 or more years Ocean Quahog clam — 405 years

Some animals do not “age” in normal way

Page 107: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

LARGER SCALE

Page 108: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

InmanyEUna*ons,>70%ofretailspendin<8companies

Page 109: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 110: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 111: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

VW mega platform

VWMegaPlajorm-basisfor1mcars

Page 112: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 113: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 114: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

World too small for more than:

5 large auto companies2 airline manufacturers

3 mobile operating systems

10 large pharma

Page 115: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

SOUTH to

SOUTH

Page 116: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

South to South” Trade will grow

Page 117: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

8%wageinfla*oninChina-partoffsetbycurrencyfall

Page 118: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

FundingofHealthCarewillbeverysensi*vepoli*calissue

Page 119: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 120: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Manyhealthcostswillfallrapidlyper

treatmentwhiletotalspendwillrise5%paglobally(7%inAsia)

Page 121: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

Pa*entAdvocacyHelpsickpeoplegettheverybesttreatment

Ra*oningcanbeirra*onalButclear,compellingdatareallymaaers

MedtechdataisooenverypoorPharmadataisooenmainlylimitedtotrials

Totalpa*entcostperdiagnosis-combina*ons“Greatestgoodforgreatestnumber”

Qualityoflifeaswellas“hard”outcomeImpactonsocietyasawhole?

Whatelsecouldtheydowiththemoney?

Page 122: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA
Page 123: Future of Pharma - trends in pharma and impact on manufacturing - conference keynote speaker on parma industry for TEVA

MakingLifeBeaer

Everydayforeverypa*ent